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Cross-regulation of Connexin43 and b-catenin
influences differentiation of human neural
progenitor cells
F Rinaldi1, EM Hartfield1, LA Crompton1, JL Badger1, CP Glover1, CM Kelly2, AE Rosser2,3, JB Uney*,1 and MA Caldwell*,1
Connexin43 (Cx43) is the most widely and abundantly expressed gap junction (GJ) protein and it is strongly associated with the
regulation of cell cycle progression. Emerging roles for Cx43 in cell adhesion and migration during neural differentiation have
also been recently recognized, and this has emphasized the involvement of Cx43 in different physiological process beyond its
role as a GJ protein. In this study, we explore the function of Cx43 in the differentiation of human neural progenitor cells (hNPCs)
using viral vectors that mediate the overexpression or knockdown of the protein. Results showed that in the absence of this
protein fetal cortex-derived hNPCs differentiated toward a neuronal phenotype at expenses of a glial phenotype. Furthermore,
the silencing of Cx43 did not affect hNPC proliferation rate or numbers of apoptotic cells. The increase in the number of neurons
was not recapitulated when GJ intercellular communications were pharmacologically blocked, and this suggested that Cx43 was
influencing hNPCs differentiation with a GJ-independent effect. In addition, Cx43 knockdown significantly increased b-catenin
signaling, which has been shown to regulate the transcription of pro-neuronal genes during embryonic neural development.
Our results add further support to the hypothesis that Cx43 protein itself regulates key signaling pathways during development
and neurogenesis beyond its role as GJ protein.
Cell Death and Disease (2014) 5, e1017; doi:10.1038/cddis.2013.546; published online 23 January 2014
Subject Category: Neuroscience
Connexin43 (Cx43) protein has been found to be expressed
early during mouse embryogenesis, at the preimplantation
stages.1 Indeed when organogenesis occurs, the protein has
been reported to be preferentially upregulated in the ectoderm
rather than mesodermal and endodermal layer.2 Interestingly
during neurogenesis, Cx43 is both temporally and spatially
regulated with a prominent expression in neural progenitor
cells followed by a decrease when neurons start to
differentiate.3 The presence of Cx43 at the early stage of
development together with its dual regulation during neuro-
genesis strongly suggest this protein is greatly involved in
development events and the precise regulation of the protein
expression maybe crucial to ensure a proper maturation.
Cx43 is one of the proteins that form Gap junction (GJ)
channels between adjacent cells, and this type of cellular
communication is critical to several processes ranging from
tissue homeostasis and synchronization of cellular activity,
to the establishment and maintenance of cell microenviron-
ments or niches.4 Several Cx proteins have been identified
that form GJs, intriguingly Cx43 is the most widely and
abundantly expressed isoform with a unique long C-terminal
(CT) tail. This has been reported to be the binding site of
multiple proteins, which dynamically interact, and participate
in the regulation of physiological events (for review,
see Giepmans5). The importance of Cx43 in regulating cell
adhesiveness and directionality of migration has recently
been described (for review, see Matsuuchi and Naus6). Cx43
is present on radial glia fibers at the points where they contact
with migrating neurons7 and Cx43 conditional knockout mice
show delayed neuronal migration8 together with impairment in
the lamination of the neocortex.9 A brain transcriptome
analysis identified gene transcripts altered in Cx43 null
and Cx43 heterozygous mice, highlighting a change in
proteins regulating cell growth, neuronal survival and
differentiation.10–12 Therefore, it is clear that together
with physically mediating neurogenesis events, Cx43 might
also act as a central role in the control of growth.11
Neural stem cells have been identified in both the
developing and adult nervous system.13–17 In this study, we
use neural progenitor cells (NPCs) derived from human fetal
brain to unravel the role of Cx43 in neuronal differentiation.
We found that Cx43 protein knockdown increased the number
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of neurons differentiated from human NPCs (hNPCs).
We further demonstrated that the knockdown of the protein
enhanced the transcriptional activity of b-catenin, which is a
key mediator of the canonical WNT pathway and it has been
shown to regulate transcription of pro-neuronal genes.18–20
Results
Human Cx43 expression in an in vitro model of
neurogenesis. We analyzed the spatiotemporal expression
of the human Cx43 (hCx43) protein in hNPCs. Those cells
provide a valuable source of neural tissue and an in vitro
model for studying neurogenesis.21 RT-PCR was performed
in multipotent hNPCs, as well as following 7 and 14 days
differentiation. Results indicated a specific pattern of Cx43
mRNA expression during hNPCs differentiation with
higher levels of Cx43 mRNA in undifferentiated and 7 days
differentiated cells (0.93±0.2; 0.69±0.1), followed by a
decrease at 14 days of differentiation (0.3±0.2; Figures 1a
and b). There was no change in the mRNA levels of the
neural markers Mash1 and Pax6 between undifferentiated
and 7 days differentiated hNPCs (undifferentiated Pax6
1.7±0.8, MASH1 1.7±0.9; 7 days differentiated Pax6
1.5±0.2, MASH1 1.4±0.2). At 14 days of differentiation,
we observed a small reduction in Pax6 expression (1.0±0.2),
whereas Mash1 levels remained consistent with previous
Figure 1 Cx43 expression in an in vitromodel of neurogenesis. (a) Representative RT-PCR bands of undifferentiated, 7 and 14 days differentiated hNPCs for Cx43, Pax6
and MASH1 mRNAs. GAPDH is used as housekeeping gene. (b) Quantification of RT-PCR bands for hCx43, Pax6 and MASH1 genes. Values are the means of three
independent experiments and error bars represent S.E.M. Values were expressed as arbitrary units normalized to the GAPDH values. (c) Fluorescence microscopy of
undifferentiated hNPCs stained with Cx43 (green), nestin or Tuj1 (red) antibodies. Cell nuclei are indicated by DAPI (blue) staining. Scale bar 50 mm. (d) Higher magnification
of the area around 7 days differentiated sphere. Cx43 (red) on GFAP (green)-positive cells expressed at the contact points with migrating Tuj1 (blue) neurons (arrowheads in
boxed areas). Scale bar 50mm
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expression (1.4±0.3; Figures 1a and b). Those results
suggested that as differentiation progressed cell were main-
taining a neural phenotype with a decrease in Cx43 expression.
Multipotent hNPCs revealed an intense Cx43 immuno-
labeling throughout the neurosphere, these cells were all
undifferentiated neuroepithelial cells as indicated from the
nestin staining (Figure 1c). Following 7 days of differentiation,
immunostaining revealed presence of Tuj1 and GFAP-
positive cells with the Cx43 protein specifically localized at
the contact points of migrating neurons and GFAP-positive
process (Figure 1d).
Lentiviral vector mediated specific knockdown of hCx43.
To induce a specific hCx43 protein knockdown, we designed
four short hairpin RNA (shRNA) constructs (Supplementary
Table 1) and cloned them into pCR 2.1. TOPO.
The efficiency of knockdown mediated by each construct
was tested in HEK293 cells by co-transfection of shRNA
plasmid together with an hCx43-overexpressing vector.
This co-transfection was required as HEK293 cells do not
express detectable levels of endogenous Cx43 protein.
Immunoblot analysis was performed to detect the shRNA
sequence allowing the maximum hCx43 protein knockdown
(Supplementary Figures 2A and B). Subsequently, the
shRNA sequence mediating the most effective knockdown
was cloned into a lentiviral vector backbone to generate viral
particles (Figure 2a). Viral efficacy was tested using multi-
plicity of infections (MOIs) of 1 and 5 in HEK293 cells. Again
an hCx43shRNA virus was used together with an hCx43-
overexpressing virus (Figures 2b and c). High transduction
efficiency was obtained at both MOIs tested (Figure 2b),
however, western blot results revealed a higher hCx43
protein knockdown at MOI 5 (Figure 2c).
Knockdown of hCx43 regulates hNPC neuronal
differentiation. We sought to investigate the contribution
of hCx43 to neurogenesis by knocking down this protein in
hNPCs and then inducing their differentiation. Figure 3a
illustrates the experimental model used in which viral
transduced hNPCs were expanded for 10 days from the
day of lentiviral vector transduction followed by differentia-
tion, which was carried out for 2 h and for 7 days,
respectively. Strong enhanced green fluorescent protein
(EGFP) fluorescence was detectable at all-time points tested
(Figure 3b) indicating continuous shRNA expression. Immuno-
cytochemistry performed in 7 days differentiated cells
revealed a robust knockdown of hCx43 protein compared
with EGFP control (Figure 3c). Quantification of nestin-
positive cells after 2 h of differentiation revealed that the
majority of cells still retained an immature neural phenotype
(Supplementary Figure 3A). The shRNA-mediated knock-
down of hCx43 resulted in a significant increase in the
number of Tuj1-positive cells compared with cells transduced
with either EGFP or a scrambled control (SC; Figures 4a and
b and Figures 5a and b) for both 2 h (shCx43 6±0.9%; EGFP
2±0.3%; SC 1±0.2%; Pr0.01) and 7 days (shCx43
31.4±5.0%; EGFP 9.1±0.4%; SC 7.0±0.7%; Pr0.01)
differentiation. The number of GFAP-positive cells was
significantly reduced in cells differentiated for 2 h compared
with EGFP control (shCx43 74±4.0%; EGFP 88±2.1% SC
86.0±2.2%; Pr0.05) and in 7 days differentiated cells
compared with EGFP and to SC transduced cells (shCx43
66±1.0%; EGFP 85.6±2.8%; SC 84.4±3.0%; Pr0.01),
(Figures 5c and d). Characterization of neurons derived from
7 days differentiated hNPCs revealed a great majority
of GABA-positive neurons (Supplementary Figure 4).
However, hCx43 knockdown did not affect the number of
actively dividing cells as indicated by Ki67 expression
(Figures 5e and f). As we detected an alteration in cell
fate commitment already at 2 h of hNPCs differentiation,
we decided to investigate whether Cx43 knockdown could
affect the viability and proliferation at this earlier stage.
Figure 2 Validation of lentiviral expression cassette. (a) Schematic of lentiviral vector expression cassette for hCx43 and hCx43ShRNA. (b) Bright field (left panels) and
EGFP expression (right panels) of viral MOI 1 and 5 transduced HEK293 cells. Scale bar 50 mm. (c) Western blot bands of hCx43 protein in viral MOI 1 and 5 transduced
HEK293 cells
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To assess cell proliferation, 50-bromo-2-deoxyuridine (BrdU)
was added to hNPC medium at the moment of viral
transduction and left in culture for the expansion time (10
days). Cells were differentiated for 2 h and analysis indicated
that hCx43 absence did not affect the proliferation
(Supplementary Figure 3B). For cell viability analysis,
TUNEL assay was performed on cells differentiated for 2 h,
and this also revealed no difference between conditions
(Supplementary Figure 3C). Finally, morphometric analysis
of neurons derived from hCx43 and control transduced
hNPCs did not reveal any change in neuronal complexity
between groups (Supplementary Figure 5), indicating that
the absence of Cx43 increased the number of differentiated
neurons, however, it did not advance neuronal maturation.
Increase in neuronal differentiation is caused by the
absence of hCx43 protein. In order to evaluate whether the
increase in neuronal number was due to the specific absence
of hCx43 protein or to a general reduction of hCx43-mediated
GJ intercellular communication, we used a pharmacological
blockade of GJ using a well-established GJ blocker
carbenoxolone (CBX).22 CBX used at 50 mM largely impaired
the spread of GJ permeable dye Cascade blue
(Supplementary Figure 6), thus we incubate hNPCs for 10
days with CBX and we used its inactive analog glycyrrhizic
acid (GZA) as control. Cells were differentiated for 2 h and
results showed in Figure 6 indicated that CBX did not affect
the number of Tuj1 or GFAP-positive cells (Figure 6a and b),
nor cell proliferation (Figure 6c). Thus, these results
suggested that the effect on hNPCs neuronal fate was
independent of GJ intercellular communications, but dependent
on the expression of the hCx43 protein itself.
hCx43 contributes to the regulation of b-catenin
transcription. We confirmed a role for hCx43 in hNPCs
differentiation and we also demonstrated that the protein
itself was responsible for the increase in the number of
neurons and a concomitant decrease in glial cells. We next
wanted to investigate a possible contribution of hCx43 to
the canonical Wnt/b-catenin pathway, which has been shown
to be involved in many aspects of embryonic development
and neurogenesis.18–20 In addition, b-catenin has also
been reported to regulate hCx43 transcription.23 We first
performed immunocytochemistry to determine the levels of
hCx43 and b-catenin proteins in hNPCs derived neuro-
spheres, which had been differentiated for 2 h. Results
revealed intense immunolabeling of both proteins, which was
mainly localized in the cell membrane (Figure 7a). We then
assessed if the knockdown of endogenous hCx43 or its
forced expression was affecting b-catenin protein expression.
We transduced hNPCs with our shCx43 or our viral vector
containing the hCx43 full-length sequence or our EGFP
control and we collected proteins for immunoblot analysis.
Results indicated a significant increase in b-catenin protein
expression when hCx43 was silenced (Figures 7b–d; shCx43
3.2±0.83; Cx43 0.8±0.14; EGFP 1±0.0; Pr0.01). Then,
we tested the hypothesis that in the absence of hCx43 the
increase in b-catenin protein expression observed was due
to an increase in the uncomplexed form of the protein. Free
cytoplasmic b-catenin accumulates in the cytoplasm and
then translocates to the nucleus where it mediates gene
transcription binding to the TCF/LEF transcription factor
motifs. Therefore, to measure b-catenin transcriptional
activity we used a well-established gene reporter assay.24
In the assay, a plasmid containing the TCF/LEF-binding site
upstream of a Firefly luciferase ORF (Addgene, Cambridge,
MA, USA) is used (TOPFLASH), together with a mock control
plasmid (FOPFLASH). In the absence of hCx43, we found
a significant increase in TCF/LEF luciferase activity when
stimulated with WNT1 agonist CHIR (6-[[2-[[4-(2,4-dichloro-
phenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]
ethyl]amino]-3-pyridinecarbonitrile) at 1.5 mM25 (Figure 7e),
compared with control EGFP transduced cells (shCx43
2.2±0.7; EGFP 1.1±0.3) and compared with hCx43-
overexpressing cells (shCx43 2.2±0.7; hCx43 0.6±0.4;
Pr0.05). Interestingly, we also found a significant decrease
Figure 3 Experimental model and validation of ShRNAhCx43 virus in neural stem cell culture. (a) Schematic representation of experimental method used to transduce
hNPCs. hNPCs were transduced at day 0 (D0) and expanded until D10 (green line). Subsequently, they were differentiated for 2 h or 7 days, respectively, (red lines). (b) EGFP
expression in undifferentiated, 2 h and 7 days differentiated hNPCs. Scale bar 50 mm. (c) Fluoresce microscopy for Cx43 (red) and EGFP (green) of 7 days differentiated
hNPCs in EGFP and shRNAhCx43 transduced cells. Cell nuclei are indicated by DAPI (blue) staining. Scale bar 50 mm
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in TCF/LEF luciferase activity when hCx43 was
overexpressed compared with EGFP control (hCx43
0.6±0.4; EGFP 1.1±0.3; Pr0.05). Thus, we can conclude
that the knockdown of Cx43 protein increased b-catenin
protein transcriptional activity, which enhanced neuronal
differentiation.
Discussion
Cx proteins are differently regulated during neuro-
genesis.26–30 Cx43 is one of the major isoforms in the
developing brain,31 being highly expressed in (E10.5) multi-
potent neural stem cells32 and in proliferating cells during
Figure 4 Tuj1 expression in viral transduced hNPCs and differentiated for 2 h or 7 days. Fluorescence microscopy of viral transduced hNPCs 2 h (a) and 7 days (b)
differentiated cultures. Left panels represent EGFP protein (green) expressing cells stained for Tuj1 (red). Cell nuclei are indicated by DAPI (blue) staining. Right panels
indicate Tuj1 (red) and DAPI (blue) staining only. Scale bar 50 mm
Figure 5 Quantification of Tuj1, GFAP and Ki67 expression in viral transduced hNPCs. (a and b) Number of Tuj1-expressing cells in 2 h (a) and 7 days (b) differentiated
cultures. (c and d) Number of GFAP-expressing cells in 2 h (c) and 7 days (d) differentiated cultures. (e and f) Number of Ki67-expressing cells in 2 h (e) and 7 days
(f) differentiated cultures. Values are the means of three independent experiments and error bars represent S.E.M. Values were expressed as % on total cell number.
*Pr0.05, **Pr0.01
Cross-regulation of Cx43 and b-catenin
F Rinaldi et al
5
Cell Death and Disease
development.27 Furthermore, its levels decrease as NPCs
differentiate into neurons,33 thus suggesting Cx43 has an
important role in neurogenesis. This is a very dynamic
process orchestrated by proliferation and differentiation of
NPCs, which contribute to the development and maturation of
a highly complex neural network. We used human NPCs
isolated from the developing cortex as an in vitro model
of human neurogenesis.34 hNPCs are EGF and FGF-2
responsive and can be expanded for 4200 days in culture
while retaining the ability to differentiate into neurons and
glial cells.35 In this study, we confirmed that the expression of
Cx43 was found in undifferentiated hNPCs but decreased as
differentiation progressed out to 14 days. This is in
keeping with what has been reported for the rodent brain.33
Following 7 days of differentiation, Cx43 was only present in
GFAP-positive cells, indicating that when cells start to
differentiate Cx43 expression is restricted to the glial
phenotype. Interestingly, we found Cx43 punctate immunos-
taining at contact points between GFAP fibers and
Tuj1-positive cells. This was in line with other rodent studies
in which Cx43 was found to mediate tangential and radial
migration of newborn neurons from the ventricular zone to the
cortical plate.7,30,36 We designed and validated an shRNA
construct to specifically knockdown hCx43 protein expression
and then we generated lentiviral particles to deliver
this construct into hNPCs. Cx43 knockdown resulted in a
significant increase in the number of neurons derived from
hNPCs both after 2 h and 7 days of differentiation. Interestingly,
we also found a significant decrease in the number of GFAP-
positive cells at the two time points examined. In vivo
neurogenesis involves differentiation of neurons first, followed
by glial cells,37 which suggests that in our system the increase
in the number of neurons might reduce the pool of progenitor
cells available to acquire an astrocytic phenotype at later
time points. Alternatively as Cx43 in the mature brain is only
expressed in astrocytes, it could be possible that the absence
of the protein impaired or delayed astrocytic differentiation.
Morphometric analysis revealed that the increase in neuronal
phenotype when Cx43 was silenced did not correspond to an
increase of neuronal complexity including cell body size,
number and length of neurites. This suggests that this protein
is not involved in the process of neuronal maturation, findings
similar to what we recently reported for Cx36 in neurons
derived from rat NPCs.38 In addition, we show that knockdown
of Cx43 does not affect cell proliferation or cell death.
Taken together, these results suggest that Cx43 knockdown
increases neuronal commitment rather than influencing
neuronal complexity, cell death or NPC proliferation.
Similarly, in vivo models of neurogenesis have shown
that hCx43 is highly expressed at early stages of neuro-
genesis30,39 and Cx43 has been reported to mediate GJ
coupling between neuroblasts in the hippocampus in mice.26
However, as progenitors start to differentiate, the degree of
cellular communication together with Cx43 protein expression
is decreased.29 The reduction in Cx43 expression and
consequent disruption in neural progenitor coupling as
differentiation occurred, suggests that Cx43 and GJ intra-
cellular communication are important in the early stages of
neurogenesis to maintain progenitors in an undifferentiated.29
Therefore, we investigated if the increased neuronal
fate commitment we observed following hCx43 knockdown
was due to a decrease in cellular communications or to the
absence of the protein itself. Pharmacological blockade of
GJICswith a generic GJ blocker (CBX) did not recapitulate the
effects of Cx43 knockdown, suggesting a channel-independent
role of Cx43 in the regulation of neuronal differentiation.
Previous studies have established that the Cx43 adhesive,
scaffolding and cell signaling-mediating properties are active
factors during neurogenesis.7–9,36,40,41 Interestingly, Cx43-
CT region contains multiple phosphorylation sites and binding
domains, which not only modulate Cx43 protein functions but
also allow Cx43 interaction with cytoskeletal elements and
other cell membrane proteins including ZO1-2, adherens
junction (AJ) proteins, cadherins and b-catenin (reviewed in
Matsuuchi and Naus
6
). b-Catenin signaling has a key role in
neuronal differentiation,18 indeed, b-catenin through the
TCF/LEF complex regulates the transcription of genes
involved in cell adhesion, proliferation and differentiation such
as E-cadherin, neuronal cell adhesion molecule, c-MYC and
cyclin D1.42,43 Furthermore, Cx43 promoter contains three
TCF/LEF binding sites.23 We stained Cx43 and b-catenin in
hNPCs differentiated for 2 h and found that both proteins were
abundantly expressed. We also detected areas in which the
two proteins were colocalized, indicating a possible functional
cross-regulation. Further experiments showed an increase in
b-catenin protein expression following hCx43 knockdown and
Figure 6 Quantification of Tuj1, GFAP and Ki67 expression in hNPCs
expanded in the presence of CBX. Number of Tuj1 (a), GFAP (b) and Ki67 (c)
expressing cells in 2 h differentiated cells. GJs were blocked by addition of CBX
50mM. GZA was used as inactive analog of CBX. Values are the means of three
independent experiments and error bars represent S.E.M. Values were expressed
as % on total cell number
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more importantly no changes in b-catenin were observed
using different shRNA constructs, confirming direct link
between hCx43 knockdown and b-catenin protein expression.
We also confirmed that the transcriptional active form of the
b-catenin protein was enhanced in the absence of hCx43.
In the cell, b-catenin is found at the cell membrane in complex
with E-cadherin to form AJs. In the absence of WNT ligands,
cytoplasmic b-catenin levels are kept low as the protein is
phosphorylated by glycogen synthase kinase 3b (GSK-3b)
and then targeted for ubiquitination and degradation.
The activation of WNT pathway induces b-catenin
dephosphorylation, nuclear translocation and the formation
of a transcriptionally active complex with LEF and TCF sites.
In cardiac cells, a complex of Cx43/b-catenin proteins have
been described at the cell membrane following stimulation of
WNT pathway.44 This evidence together with the presence of
b-catenin binding sites in the Cx43 promoter region raised the
possibility of a dual regulation between the two proteins.
Cx43 may serve to negatively regulate its own transcription
through b-catenin, as well as participate in the regulation of
other b-catenin targets such as pro-neuronal genes18–20 by
sequestering b-catenin to the cell membrane. Thus, in
hNPCs, hCx43 knockdown disrupted the protein junctional
complex with b-catenin leading to an increase in b-catenin
nuclear translocation, transcription of pro-neuronal genes and
an increase in the number of neurons. A dual regulation
between gene transcription and cell adhesion molecules
has already been described in a model proposed by
Orsulic et al.,45 in which E-cadherin antagonized b-catenin
signaling activity. In conclusion, in our investigation we have
provided evidence for an interaction occurring between Cx43
and b-catenin proteins during neurogenesis. Furthermore,
our results suggest a novel approach to increase the
number of neurons from hNPCs, opening novel frontiers for
research applications.
Materials and Methods
Design and construction of hCx43 shRNA lentiviral vector. The
hCx43 sequence (accession no. NM.000165.3) was used to generate four hCx43
shRNAs (Supplementary Table 1). Sh expression cassette comprised a sense
Figure 7 hCx43 protein knockdown increases b-catenin transactivation. (a) Confocal microscopy of 2 h differentiated hNPCs. Cells were stained for b-catenin (red) and
Cx43 (green) proteins. Cell nuclei are indicated by DAPI (blue) staining. Scale bar 50 mm. (b and c) Representative western blot bands of hCx43 (b) and b-catenin proteins (c)
in viral transduced hNPCs. a-Tubulin was used as internal control. (d) Quantification of b-catenin protein expression by densitometry. Values were normalized to values of
internal control. *Pr0.05 (e) Quantification of active b-catenin by luciferase gene reporter assay. Values of transcriptional active b-catenin were determined by the level of
luciferase activity and normalized to the internal control (Renilla luciferase plasmid). Values are the means of three independent experiments and error bars represent S.E.M.
Values expressed as relative activation compared with cells transfected with a b-catenin-LEF/TCF insensitive (FOP) reporter vector. *Pr0.05
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and an antisense (antisense specific to the target mRNA) strand spaced by a loop
sequence, a RNA polymerase III transcription termination signal and XhoI
restriction site. A sequence coding for the mouse U6 promoter was inserted
upstream of the antisense strand (Supplementary Figure S1A). A PCR-based
method was used to generate double-stranded shRNA expression cassettes
using the pSilencer 1.0-U6 expression vector (Life Technologies, Carlsbad, CA,
USA) as a transcription template and reverse primer encoding the shRNA
oligonucleotides. shRNA constructs were cloned into pCR2.1-TOPO vector as
previously described46 and validated for specific hCx43 protein knockdown
(Supplementary Figures S2A and B). Successful shRNA cassette was then
excised by digestion with EcoRI and inserted into the lentiviral backbone plasmid
via MfeI site generating the pRRLsincppt.U6.hCx43shRNA.CMV.EGFP.wpre
construct (Figure 2a).
Construction of lentiviral vectors expressing hCx43, EGFP or
SC. The hCx43 coding sequence was excised from pDest40.hCx43 plasmid
(GlaxoSmithKline, Harlow, UK) using NdeI and AgeI restriction endonucleases and
cloned into pRRLsincppt.CMV.polyAB.IRES2.EGFP.wpre construct via NdeI and
AgeI sites generating pRRLsincppt.CMV.hCx43.IRES2.EGFP.wpre (Figure 2a).
Lentiviral vector coding for EGFP under CMV promoter pRRLsincppt.
CMV.EGFP.wpre and a sh SC sequence under a U6 promoter pRRLsincppt.
U6.SC.CMV.EGFP.wpre were constructed as previously described.21
Human neurosphere cell cultures and lentiviral vector
transduction. hNPCs were derived from 9 to 10 weeks old (post-menstrual)
human fetus in line with the UK Department of Health guidelines and according to
the Local Research Ethic Committee approval. hNPCs were expanded as
neurospheres in presence of growth factors EGF and FGF-2 (20 ng/ml) and
heparin (5 mg/ml) as previously described.34 Neurospheres were expanded for a
maximum of four passages (2 months) before being transduced with lentiviral
vectors. This was performed in order to eliminate any primary cells from the
culture. To induce differentiation, neurospheres were dissociated with Accutase
(Sigma-Aldrich, St. Louis, MO, USA) and plated onto poly-D-lysine/laminin-coated
glass coverslips. Medium consisted in DMEM/F12 (7 : 3; GIBCO, Life
Technologies), 2% B27 and 1% penicillin/streptomycin as previously described.35
Cell differentiation was carried out for 2 h and 7 days, respectively. For lentiviral
vector transduction, neurospheres were dissociated into single cells using
Accutase (37 1C 15min; Sigma) and seeded at 105 cells per well in poly-HEMA
(120 g/l) coated 96-well plate. Viruses were added while cells were in single-cell
suspension using a viral MOI of 5. Medium was doubled the following day and
cells were transferred to a 12-well plate at 4 days after transduction and expanded
for further 6 days before differentiation.
Immunocytochemistry, BrdU and TUNEL assays. Immuno-
cytochemistry was performed on cells fixed with 4% PFA (15min). Cells were
blocked for 2 h in 10% goat serum, 2% BSA in 0.1%Triton-X100 PBS solution and
then processed for primary and secondary antibodies immunoreaction. Primary
and secondary antibodies are detailed in Supplementary Table 2. BrdU
incorporation analysis was performed in cells differentiated for 24 h. Briefly,
0.2mM BrdU (Sigma) was added in the expansion medium at the time of viral
transduction. Following cell fixation, cells were permeabilized with ice-cold
methanol for 20min at  20 1C and then treated with 2 N HCl for 20min at 37 1C
HCl (1M, 30min). Subsequently, cells were washed in borate buffer
(0.1 M, 12min) and blocked for 2 h in 10% goat serum and 2% BSA. Incubation
with anti-BrdU antibody (Supplementary Table 2) was performed overnight
at 4 1C. TUNEL cell death assay was carried out following the manufacturer’s
guidelines (Roche, Mannheim, Germany).
Western blot and densitometry analysis. For western blot, cells were
lysed in RIPA buffer (50mM Tris-HCL, pH7.4; 150mM NaCl; 1% Triton-X100;
1% sodium deoxycholate; 0.1% sodium dodecyl sulfate supplemented with protease
and phosphatase inhibitors (Roche). Protein concentration was determined by a
BCA protein assay (Thermo Scientific, Waltham, MA, USA) and 30 mg of protein
were resolved on 10% SDS-Tris glycine gel. Proteins were blotted onto PVDF
membranes (Roche) and membranes blocked in 10% non-fat dry milk in 0.1%
Tween-20 (Sigma) TBS overnight. Primary and secondary (HRP conjugated;
Amersham, GE Healthcare, Little Chalfont, UK) antibodies were prepared in 5%
non-fat dry milk in 0.1% Tween-20 (Sigma) TBS buffer (Supplementary Table 2).
Protein bands were visualized with ECL plus Western blotting detection reagent
(Amersham). Autoradiographic film (Amersham) was exposed to the membrane
and developed using a Kodak (Rochester, NY, USA) film processor.
Densitometry analysis was carried out using ImageJ free image processing
software (http://rsb.info.nih.gov/ij/) and protein values were quantified and
normalized to the alpha-tubulin internal control signals. The mean of three
individual experiments was calculated.
Reverse transcription and PCR. RNA was isolated from hNPCs or
differentiated cells using the RNeasy mini system (Qiagen, Hilden, Germany).
Isolated RNA was treated with RNAse-free DNAseI (Roche) to remove genomic
DNA. Samples were cleaned up using the RNeasy minelute kit (Qiagen) and RNA
quantity and quality was determined by spectrophotometry. RNA (1 mg) was
retro-transcribed using the Superscript III system (Life Technologies) according
to manufacturer’s instructions. PCR was carried out using the GoTaq system
(Promega, Madison, WI, USA) according to manufacturer’s instructions. Primer
sequences are indicated in Supplementary Table 3. PCR products were
separated on 1.5% agarose gel containing 200 mg/ml ethidium bromide
(Sigma), and visualized using a GelDoc-IT UV imaging system (UVP, Upland,
CA, USA). PCR band intensity was analyzed by densitometry using ImageJ
software and mRNA levels were normalized to the GAPDH mRNA. The mean of
three different experiments was plotted and transcript level expressed as
arbitrary units.
Pharmacological blockade of GJ intercellular channels. hNPCs
were treated with 50mM of CBX (Sigma) and 50mM of the CBX inactive analog
GZA (Sigma) for 10 days. CBX or GZA containing media was replaced every
3 days to avoid drug depletion. hNPCs were differentiated for 24 h.
Luciferase reporter assay. b-Catenin transcription was assessed using
the TOP FLASH/FOP FLASH reporter luciferase assay.24 For TOP FLASH/FOP
FLASH reporter luciferase assay, hNPCs were dissociated with Accutase (37 1C
15min; Sigma) and plated onto poly-D-lysine-coated 24-well plates at 105 cells per
well in differentiation medium. WNT pathway was stimulated adding 1.5mM CHIR
(WNT1 agonist, TOCRIS Biosciences, Minneapolis, MN, USA) at the time of plate
down and kept in the medium until the cells were harvested. The following day
cells were co-transfected using Fugene 6 (Roche) with 0.99mg of b-catenin-LEF/
TCF-sensitive (TOP) or b-catenin-LEF/TCF insensitive (FOP) reporter vector
(Addgene) together with 0.1mg of a constitutively active Renilla luciferase
construct (Promega) for normalization of transfection efficiency. Cells were
processed 48 h after co-transfection for Luciferase reporter activity using the Dual
Luciferase Reporter System (Promega) according to the manufacturer’s
instructions.
Validation of hCx43 shRNA constructs. Knockdown activity of hCx43
shRNA constructs was tested in HEK293 cells by transient transfection.
Briefly, cells were plated at 7 104 cells per well and co-transfected with
0.8mg of hCx43 shRNA constructs together with 0.2mg of pDest40.hCx43 using
Fugene 6 (Roche). Cells were harvested 48 h following transfection and processed
for western blot analysis.
Image acquisition and data analysis. Fluorescence microscopy was
performed on 4% PFA fixed cells using Leica DM IRB inverted or LEICA DM RB
upright microscopes (Leice, Wetzlar, Germany). Images were taken using  20,
 40 and  60 lenses. Neuronal cell body area and neurite branching were
analyzed using the ImageJ plugin Simple neurite tracer (http://rsb.info.nih.gov/ij/).
All experiments were performed at least three times on samples derived from
three different fetuses. Values were expressed as mean±S.E.M. P-values
were calculated using Graphpad Prism 4 software (GraphPad, San Diego, CA,
USA) by one-way ANOVA followed by Newman–Keuls post-hoc test. *Pr0.05,
**Pr0.01.
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